baber/WOPTO huggingface dataset:
Patent NZ-223877-A (NZ)
Title: Multilayer stretch/shrink film of at least seven layers, mostly of polyethylenes
Inventor: HERRAN VINCENT WAYNE
IPC: B32B7/02
Filed: 1988-03-15
Abstract: A multi-layered thermoplastic polyolefin film having an improved combination of physical characteristics is disclosed. In particular, the multi-layered film evidences an improved combination of abuse resistance, elongation, and flexibility. Preferred five layer embodiments of the film comprise (1) a core layer of very low density polyethylene; (2) two adjacent intermediate layers of a linear low density polyethylene and (3) two outer layers of an ethylene vinyl acetate copolymer or very low density polyethylene.
Patent NZ-232158-A (NZ)
Title: Adhesive dressing containing an antineoplastic drug e.g. 5-fluorouracil
Inventor: MULLER WALTER
IPC: A61P35/00
Filed: 1990-01-18
Abstract: The invention relates to a surface treatment system consisting of an impermeable backing layer, of an agent-containing matrix and of a protective layer which can be detached again, where the matrix contains:
 a. an antineoplastic agent
 b. a self-adhesive polyacrylate
 c. a water absorber
 and where appropriate
 d. a non-adhesive hydrophilic polyacrylate
 e. an emollient and/or penetration promoter.
Patent NZ-232733-A (NZ)
Title: Optically active sulphone derivatives
Inventor: DELUCA HECTOR F
IPC: C07C315/02
Filed: 1990-02-28
Abstract: This invention provides a novel method for the preparation of optically active arylalkylsulfone derivatives, having a chiral center in the alkyl moiety in either the (R)- or the (S)-configuration. These optically active sulfones find use in the stereospecific synthesis of steroid or vitamin D compounds having chiral center at either carbon 24 or carbon 25 of the side chain.
Patent NZ-234729-A (NZ)
Title: Unexposed radiation-sensitive plates for use in lithographic printing
Inventor: WADE JOHN ROBERT
IPC: G03F7/11
Filed: 1990-07-31
Abstract: A radiation-sensitive plate comprises a substrate coated with a radiation-sensitive composition including a component having groups imparting solubility in aqueous solutions and a component having functional groups capable of reacting with a silane compound. The surface of the composition is modified by reaction with a silane compound. The plate gives rise to images of improved ink receptivity and can be developed in aqueous developer liquids after image-wise exposure.
Patent NZ-243241-A (NZ)
Title: Detachable device for extraction of cofeee capsules from an espresso coffee making machine
Inventor: FOND OLIVIER
IPC: A47J31/40
Filed: 1992-06-19
Abstract: The invention relates to a device which allows extraction from cartridges and which can be fitted on an espresso coffee machine, comprising a cartridge-holder support (14) with a handle (17) and clamping tabs adapted to the clamping collar (2) and to the clamping surfaces (ramps) (13) of the machine, a cartridge-holder (15) accommodated in the said cartridge-holder support and a water collection part (16) mounted pivotally on the handle of the cartridge-holder support, which can be folded over the upper edge of the cartridge-holder and has a water distribution grid (24). <IMAGE>
Patent NZ-261923-A (NZ)
Title: Continuous digester chemical pulp strainer: self supporting unit
Inventor: CARLSSON JAN G
IPC: D21C3/24
Filed: 1994-01-14
Abstract: PCT No. PCT/SE94/00020 Sec. 371 Date Aug. 14, 1995 Sec. 102(e) Date Aug. 14, 1995 PCT Filed Jan. 14, 1994 PCT Pub. No. WO94/19533 PCT Pub. Date Sep. 1, 1994The present invention relates to a straining device in association with the displacement of liquid through a pulp bed preferably in connection with the withdrawal of cooking liquid in a continuous digester (1) for producing chemical pulp, which straining device (2) is preferably rectangular and comprises a number of strainer-bars (3), arranged in parallel, which have been fixed to at least two rod elements (4, 5), which are placed transversely in relation to the lengthwise extension of the bar-strainers, the said rod elements (4, 5) being made of metal, preferably stainless steel, and having a strength value RP 0.2 at 100 DEG  C. which exceeds 200 MPA, preferably 300 MPA, and more preferably 350 MPA, and the width of the said rod element (4) being less than 800 mm, preferably 650 mm, and more preferably 550 mm, so that the straining device becomes self-supporting.
Patent NZ-266138-A (NZ)
Title: O-acyl-4-phenyl-cycloalkanol derivatives, medicaments
Inventor: WOITUN EBERHARD
IPC: A61K31/22
Filed: 1994-04-25
Abstract: PCT No. PCT/EP94/01276 Sec. 371 Date Jan. 17, 1997 Sec. 102(e) Date Jan. 17, 1997 PCT Filed Apr. 25, 1994 PCT Pub. No. WO95/29148 PCT Pub. Date Nov. 2, 1995This document describes O-acyl-4-phenyl-cycloalkanols of general formula I    <IMAGE>  (I)  wherein n denotes the number 0 or 1, m denotes the number 1 or 2, p denotes the number 0 or 1, R1 and R2 each denote hydrogen, lower alkyl, alkenyl or alkynyl, which may optionally also be substituted, or together with the nitrogen atom between them denote 5- to 7-membered saturated, monocyclic, heterocyclic rings which may optionally also be interrupted by an oxygen or sulphur atom or by an imino group, R3, R4, R5 and R6 denote hydrogen or lower alkyl, R5 additionally denotes lower alkoxy, R7 denotes hydrogen, cycloalkyl, phenyl or substituted phenyl, naphthyl, tetrahydronaphthyl, thienyl, furyl or pyridyl and A denotes a chemical bond or alkyl, alkenyl or alkynyl having up to 17 carbon atoms, and also processes for preparing them, pharmaceutical compositions containing these compounds and the use of these pharmaceutical compositions which intervene in cholesterol biosynthesis. The antihypercholesterolaemic substances can be used for the treatment and prophylaxis of atherosclerosis; they inhibit the enzyme 2,3-epoxysqualene-lanosterol-cyclase.
Patent NZ-277769-A (NZ)
Title: Use of dimethylpolysiloxane for treating oral aphthae and stomatitis
Inventor: SCHMIDT ALFRED
IPC: A61K31/80
Filed: 1994-12-02
Abstract: The invention disclosed relates to treating aphthae by applying dimeticone to the afflicted oral mucosa.
Patent NZ-292494-A (NZ)
Title: Specific and universal probes and amplification primers for determining the presence of nucleic acids to detect and identify common bacterial pathogens and antibiotic resistant genes; sequences
Inventor: BERGERON MICHEL G
IPC: C12Q1/689
Filed: 1995-09-12
Abstract: The present invention relates to DNA-based methods for universal bacterial detection, for specific detection of the pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus pneumoniae, Staphylococcus aureus, Staphylococcus epiderminis, Enterococcus faecalis, Staphylococcus saprophyticus, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis as well as for specific detection of commonly encountered and clinically relevant bacterial antibiotic resistance genes directly from clinical specimens or, alternatively, from a bacterial colony. The above bacterial species can account for as much as 80% of bacterial pathogens isolated in routine microbiology laboratories. The core of this invention consists primarily of the DNA sequences from all species-specific genomic DNA fragments selected by hybridization from genomic libraries or, alternatively, selected from data banks as well as any oligonucleotide sequences derived from these sequences which can be used as probes or amplification primers for PCR or any other nucleic acid amplification methods. This invention also includes DNA sequences from the selected clinically relevant antibiotic resistance genes.
Patent NZ-297230-A (NZ)
Title: Thiepane compounds for detecting HIV protease
Inventor: BISCHOFBERGER NORBERT W
IPC: A61K31/38
Filed: 1995-11-03
Abstract: Patent 297230  The specification describes tri- and tetra substituted thiepanes of above formula(I) and compositions having use as immunogens and diagnostics. Y is O, S, SO, SO2, N(R1), N(R2)SO2, N(R1)CO, or OSO2. The compositions inhibit proteolytic activity of viral enzymes and are useful for the inhibition of such enzymes as well as in assays for the detection of such enzymes. Embodiments in which antigenic polypeptides are bonded to the compositions are useful in raising antibodies against the thiepane haptens or the polypeptide. Labelled thiepanes are useful as diagnostic reagents.
Patent NZ-314707-A (NZ)
Title: Treatment of female infertility or gonad protection using a lyophilisate of a peptide with 3 to 15 amino acids, such as cetrorelix
Inventor: ENGEL JURGEN
IPC: A61K47/26
Filed: 1994-02-17
Abstract: Sterile freeze-dried cetrorelix acetate (a peptide described in EP299402) is used in the treatment of female infertility. Independent claims are also included for the following: (1) use of sterile freeze-dried cetrorelix acetate for protecting gonads against noxious agents that damage germ cells, e.g. radiation treatment and chemotherapy; (2) a composition comprising sterile freeze-dried cetrorelix acetate and optionally excipients for use in the treatment of female infertility; (3) a composition comprising sterile freeze-dried cetrorelix acetate and optionally excipients for protecting gonads against noxious agents that damage germ cells, e.g. radiation treatment and chemotherapy with cytostatic agents.
Patent NZ-324672-A (NZ)
Title: A decanter centrifuge
Inventor: MADSEN BENT
IPC: B04B11/02
Filed: 1996-12-18
Abstract: The decanter centrifuge has a bowl with a screw conveyor having a body (4) and a screw (7).  Material to be separated into a light phase and a heavy phase is supplied through inlet ports (6) in the body, and the heavy phase is discharged through discharge ports in the bowl at one end of the conveyor.  Between the inlet ports and the discharge ports for the heavy phase, the body of the screw conveyor carries a baffle (8c), generally shaped as a radial rib which forms a helical surface turning in the same direction as the screw (7).  Owing to its shape, the baffle actively contributes to the transport of the heavy phase, and with retention of the same gap between the baffle and the inner surface of the bowl, the gap area can be increased by increasing the axial length of the baffle.
Patent NZ-331332-A (NZ)
Title: Electric motor starting circuit for a multiphase motor having a plurality of phase windings to be energised
Inventor: MCDONALD STEPHEN PAUL
IPC: H02P1/26
Filed: 1997-02-17
Abstract: n electric induction motor can be given a kick start without excessive current drain on the supply by first connecting a unidirectional supply to a winding of the motor to build up a stationary rotor flux and then applying a starting current to another winding of the motor to produce a stator flux at an appropriate angle (between 0 and 180) with the stationary rotor flux. Once the motor has begun accelerating the normal running supply can be connected. This starting current may be derived from a capacitance which is charged up during the period of establishing the stationary rotor flux.
Patent NZ-333914-A (NZ)
Title: Use of benzothiophene (raloxifene) derivatives in treatment of osteoporosis, lowering serum cholesterol levels and inhibiting estrogen dependent cancer
Inventor: CULLINAN GEORGE JOSEPH
IPC: A61K31/38
Filed: 1999-01-26
Abstract: This use of benzothiophenes of the formula I ; where R1 is H, OH, alkoxy, OC(O)alkyl, OC(O)Oalkyl, OC(O)phenyl, OC(O)Ophenyl or SO2alkyl, R2 is R1, Cl or F, R3 and R4 each are alkyl or combine to form a morpholine or a 5-8 membered nitrogen containing hetero ring and X is CH2, CHOH, O or CO; is for inhibiting osteoporosis, lowering serum cholesterol levels and inhibiting estrogen-dependent cancer.
Patent NZ-336263-A (NZ)
Title: Producing modified cheese whey protein by reacting the whey with a transglutaminase
Inventor: SOEDA TAKAHIKO
IPC: A23L13/60
Filed: 1999-06-14
Abstract: Described is the production of a cheese whey protein by reacting the whey protein with a transglutaminase and in association with a heat treatment and pH adjustment.  The cheese whey protein is later heated to 100° or higher to obtain a gel.
Patent NZ-502712-A (NZ)
Title: Medium and method for long term culturing of avian primordial germ cells (PGC) in a tissue culture comprising growth factors
Inventor: PONCE DE LEON F ABEL
IPC: C12N5/02
Filed: 1998-08-04
Abstract: A method for culturing avian primordial germ cell (PGCs) in tissue culture for at least 14 days comprises: a) Isolating a pure population of PGC from a desired avian. b) Culturing the isolated pure PGC in a culture medium. The culture medium comprises at least the growth factors, leukemia inhibitory factor (LIF), basic fibroblast growth factor (bFGF), stem cell factor (SCF) and insulin-like growth factor (IGF). A method for culturing chimeric avians further comprises the steps: c) Transferring the cultured PGCs into a recipient avian embryo of the same species as the PGCs were isolated from. d) Allowing the recipient avian to develop into a bird e) Selecting for chimeric avians which express the PGC phenotype. Also described is an in vitro culture consisting of purified PCG in a medium containing growth factors that provide for the PGCs to be stably maintained in vitro for at least 14 days comprising leukemia inhibitory factor (LIF), basic fibroblast growth factor (bFGF), stem cell factor (SCF) and insulin-like growth factor (IGF).
Patent NZ-509194-A (NZ)
Title: Simple sequence repeats (microsatellites) in clover
Inventor: KOELLIKER ROLAND
IPC: C07H21/04
Filed: 2001-01-03
Abstract: Simple sequence repeats (SSRs) are identified in clover.  Primers suitable for amplifying SSRs, methods for identifying SSRs and libraries enriched for SSRs are provided.  The SSRs may be used in the selection of genes in legume breeding, for profiling legume species varieties or for testing the purity of legume seed batches.
Patent NZ-511075-A (NZ)
Title: Work space management and furniture system
Inventor: KURRASCH ANDREW J
IPC: A47B21/00
Filed: 1999-10-13
Abstract: A system (10) for defining a plurality of work zones (12) within an otherwise open area. The system (10) includes a framework (16) formed from a plurality of spaced apart poles (18) extending upward from a base surface. The poles (18) are interconnected by a plurality of crossbeams (22, 24) at a height substantially above a standing user. At least some of the poles are adapted to provide a raceway for the delivery of utilities. The framework (16) is capable of being arranged in a plurality of substantially non-linear patterns and includes an at least partially open area between adjacent poles.
Patent NZ-511932-A (NZ)
Title: Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
Inventor: MARLIERE PHILIPPE
IPC: A61K38/00
Filed: 1999-10-28
Abstract: Disclosed are processes enabling prokaryotic or eukaryotic cells to acquire the capacity to produce proteins whereof the amino acid sequences comprise at least a non-standard amino acid, methods for selecting said cells, methods for producing and purifying said proteins and cells and proteins obtained by said methods and processes. Uses of said cells and proteins in various fields such as therapeutics, cosmetics, diagnosis or biosynthesis or biodegradation of organic compounds are also disclosed.
Patent NZ-513183-A (NZ)
Title: A guide method for guiding a device that is designed to insert elements into the ground in order to make a structure, and a device for inserting at least one element into the ground using such a guide method
Inventor: ROBERTSON IAN
IPC: E01B35/02
Filed: 2001-07-26
Abstract: The method involves establishing topographical points 8 with coordinates in an X, Y, Z frame of reference, and positioning a measuring station 3 in the vicinity of the structure. The position of the measuring station 3 is determined with reference to one or more l points 8. The measuring station determines the distance and angle between the insertion device 1 and the measuring station 3 in order to calculate the position of the device 1. The insertion device 1 is then located so that the insertion elements 2 are positioned above the coordinates at which they will be inserted into the ground.
Patent NZ-518828-A (NZ)
Title: 4-pyrimidinyl-N-acyl-L-phenylalanines
Inventor: SIDDURI ACHYUTHARAO
IPC: A61P19/02
Filed: 2000-11-28
Abstract: Compounds of Formula (I) are disclosed, wherein R1 to R6 are as defined in specification and which are inhibitors of binding between VCAM-1 and cells expressing VLA-4, and accordingly are useful for treating diseases whose symptoms and or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
Patent NZ-520317-A (NZ)
Title: Antiviral azaindole derivatives, pharmaceuticals thereof, and their use in the treatment of viruses such as HIV
Inventor: WANG TAO
IPC: A61K31/495
Filed: 2001-01-19
Abstract: A compound of formula I is described. A compound of formula I used for the treatment of infection by HIV, which may additionally be combined with: a) an AIDS antiviral agent; b) an anti-infective agent; c) an immunomodulator; and d) HIV entry inhibitors.
Patent NZ-528496-A (NZ)
Title: Method and apparatus for practicing carbonaceous-based metallurgy
Inventor: CALDERON ALBERT
IPC: C21B13/14
Filed: 2002-02-28
Abstract: Disclosed herein is an energy efficient, coal-based method and apparatus, a reactor (10) that are environmentally friendly which produce under pressure metallized/carbon product and molten metal directly from abundant coal or other carbonaceous material, and low cost fines (or ore concentrate) wherein the molten metal is devoid of gangue material and possesses the inherent advantage of retaining the sensible heat for subsequent processing. Particularly disclosed is a method for thermally processing a metallic oxide with a carbonaceous material in one or more chambers, wherein each of the one or more chambers has a charging end and a discharging end, to produce a hot metallized/ carbon product which is subsequently melted in a melter to make a molten metal and a molten slag, comprising: feeding the metallic oxide and the carbonaceous material to the charging end of said one or more chambers in such a way as to form a core with an annulus surrounding the core for the efficient reaction of the metallic oxide with the carbonaceous material, and forcing the metallic oxide and the carbonaceous material toward the discharging end of said one or more chambers; injecting an oxidant in such a way as to utilize at least a portion of the energy contained in said carbonaceous material to release thermal energy and produce pressurized reducing gases to reduce the metallic oxide to form a hot metallized/carbon product; discharging said hot metallized/carbon product from said one or more chambers into the melter; heating the metallized/carbon product in the melter to produce a hot pressurized off-gas, a molten metal and a molten slag; and segregating the off-gas, the molten slag and the molten metal.
Patent NZ-529337-A (NZ)
Title: Lock cylinder
Inventor: KORNHOFER ING
IPC: E05B27/00
Filed: 2003-11-04
Abstract: A lock cylinder with a cylinder plug mounted rotatably in a housing having a key channel includes a plurality of pairs of pins which are formed by the plug pins and sprung housing pins. The plug pins are located in the plug pin bores in the key channel, there being provided for at least one pair of pins, a stop which limits the depth of insertion of the plug pin in the key channel. This depth of insertions shorter than that of the other two pug pins. The stop is constructed as a sudden change of diameter of the bore in the cylinder plug, against which the housing pins abuts.
Patent NZ-531970-A (NZ)
Title: Small organic molecule regulators of cell proliferation
Inventor: BAXTER ANTHONY DAVID
IPC: A61P21/00
Filed: 2002-09-18
Abstract: Disclosed are compounds of general formulae IX , X and XI wherein the substituents are as defined in the specification. Also disclosed are pharmaceutical compositions containing compounds of formulae I, II or III. Compounds of the type disclosed are hedgehog agonists and are useful as medicaments and cosmetics for modulating differentiation or proliferation of a cell.
Patent NZ-533087-A (NZ)
Title: Potentiated topical composition comprising pentane-1,5-diol
Inventor: FAERGEMANN JAN
IPC: A61K8/20
Filed: 2002-10-18
Abstract: Described is a topical composition for skin care or administration of a pharmacologically active agent. It comprises from 5% by weight to 70% by weight of pentane-1,5-diol and a cosmetically or pharmaceutically acceptable carrier. The pharmacologically active agent is selected from the group including steroids, antimycotic agents, antiseptics and polypeptides The composition can comprise a UV-absorbing agent, a colorant, a fragrant agent, or an anionic emulsifying wax; and is in the form of a cream, liquid, lotion, ointment, paste, gel, shampoo, spray or lipstick. Also described are corresponding methods of administration and a patch for holding the composition against the skin. A proviso states that the composition does not comprise polysiloxane, volatile siloxane, phosphatidylcholine, creatine, carnitine, panthenol, pyruvic acid, monoglyceride of lauric acid, or monoglyceride of myristic acid.
Patent NZ-534212-A (NZ)
Title: Process for making stabilized grain size refractory metal powder metallurgy mill products
Inventor: AIMONE PAUL R
IPC: B22F1/00
Filed: 2003-01-21
Abstract: A powder metal (P/M) mill product and the method of fabrication such product made out of low oxygen (less than 400 ppm) refractory metal, or alloys thereof, using oxide additive (such as MgO, SiO2, and Y2O3) for co-fabrication to achieve refractory metal grain size stabilization as required in high temperature applications is disclosed. One such product is a sheet with small grain size containing oxide particles as grain size stabilizers. The product has good mechanical properties, low oxygen content in refractory metal fiber derivatives of the powder within the mill product and if is available as large pieces of sheet (lateral dimensions). The metal powder is consolidated to a sheet bar by different methods, which may weigh 50 pounds or more. Particularly disclosed is a process for making the powder metal mill product from a refractory metal powder, wherein the process comprises: (a) providing a low oxygen refractory metal powder; (b) adding a grain growth inhibitor to the low oxygen refractory metal powder before consolidating the powder; (c) consolidating the powder by either hot isostatic pressing, extrusion or another thermomechanical working process; and (d) subjecting the consolidated powder to subsequent thermomechanical processing, and thereby forming the mill product.
Patent NZ-534801-A (NZ)
Title: Partial and full agonists of A1 adenosine receptors
Inventor: IBRAHIM PRABHA
IPC: A61P9/00
Filed: 2003-02-19
Abstract: Disclosed are compounds of formula (I) that are partial and full A1 adenosine receptor agonists, wherein: R1 is optionally substituted heterocyclyl; R2 is hydrogen; R3 is optionally substituted phenyl or optionally substituted heteroaryl; R4 and R5 are independently hydrogen or optionally substituted acyl; T and X are independently a covalent bond or alkylene of 1-3 carbon atoms optionally substituted by alkyl or cycloalkyl; Y is -O- or -NH-; and Z is alkylene of 1-3 carbon atoms, optionally substituted by alkyl or cycloalkyl. These compounds are suitable for treating various disease states, in particular tachycardia and atrial flutter, angina, myocardial infarction and hyperlipidemia.
Patent NZ-536943-A (NZ)
Title: Modulation of ovulation
Inventor: JUENGEL JENNIFER LEE
Filed: 2004-12-02
Abstract: An isolated peptide fragment of the GDF-9 or GDF-9B N-terminal domain possessing the ability to modulate ovulation in a female mammal, where the GDF-9 or GDF9B N-terminal consists of SEQ ID NO: 1 and SEQ ID NO: 2 respectively, or a similarly functional derivative, homolog, analogue or mimetic. Also disclosed are pharmaceutical compositions containing the isolated peptide fragments or antibodies exhibiting binding affinity to the GDF-9 or GDF-9B N-terminus.